CAMP4 THERAPEUTICS CORPORATION (CAMP): Eigentümerstruktur
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 10,222 US Dollar | 6 | 3 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 62.753.200 | 7,5 | 11,12 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name CAMP4 THERAPEUTICS CORPORATION
Mitarbeiter 48
Handelsplatz NASDAQ
Ticker Symbol CAMP
IPO Datum 2024-10-11
Adresse One Kendall Square, Cambridge, MA, United States, 02139
Webseite https://www.camp4tx.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Joshua Mandel-Brehm | CEO, President & Director |
| 2 | Dr. Richard A. Young Ph.D. | Founder & Independent Director |
| 3 | Ms. Kelly Gold | Chief Financial Officer |
| 4 | Dr. Yuri Maricich M.B.A., M.D. | Chief Medical Officer |
| 5 | Dr. Leonard I. Zon M.D. | Founder & Chairman of Scientific Advisory Board |
| 6 | Mr. Caleb Moore | Chief Business Operations Officer |
| 7 | Dr. Daniel Tardiff Ph.D. | Chief Scientific Officer |
| 8 | Ms. Michelle Gates | Senior VP & Chief People Officer |
| 9 | Ms. Alla Sigova Ph.D. | Senior Vice President of Platform |
| 10 | Dr. Satya Kuchimanchi Ph.D. | Senior Vice President of Technical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Amvescap Plc. | 0,04% | 0,08 Mio. USD |